Stay updated on Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page
- ChecktodayChange DetectedA 2015 U.S. NIH grant/contract reference was removed from the study record, and the site revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record’s main content is displayed, including its eligibility criteria, treatment arms, outcomes, record dates, publications, and study documents.SummaryDifference60%

- Check21 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe clinical trial record for KEYNOTE-119 is no longer displayed; the page shows a 403 Forbidden message and an NIH website transition notice instead.SummaryDifference21%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.